EUVIMEDEUVIMED entdecken
Crossref

Seco-Prenylated Butylphloroglucinol Derivatives from Hypericum elodeoides and Their Anti-Alzheimer’s Disease Activities

Wenjing Tian, Shoulun He, Shengfei Zhong, Miaoyunhuan Wang, Yingting Lin, Jingyu Sun, Guanghui Wang, Xiaobin Li, Haifeng Chen iD

Organic Letters · 2025

DOI: 10.1021/acs.orglett.5c02367 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Organic Letters, 2025. Verfasst von Wenjing Tian und 8 weiteren Autor:innen. Beteiligte Einrichtung: Fujian Provincial Key Laboratory of Innovative Drug Target, School of Pharmaceutical Sciences, Xiamen University, Xiamen 361005, China. Hauptthemen laut MEDLINE: Alzheimer Disease, Phloroglucinol, Hypericum. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 25 Literaturangaben. Gefördert von: Natural Science Foundation of Fujian Province, National Natural Science Foundation of China.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Hyperelodeoines A and B (1 and 2, respectively), two unprecedented seco-prenylated butylphloroglucinol derivatives, along with two known analogues (3 and 4), were identified from Hypericum elodeoides. Compounds 1 and 2, featuring a 7/5 fused ring core, represent the first examples of phloroglucinol ring-opening products derived from the [3.2.1]-type bicyclic polyprenylated acylphloroglucinols (BPAPs). Notably, 2 and 4 significantly upregulated ABCA1 and ApoE protein levels in BV-2 cells. Dual-luciferase reporter assay, CETSA, and SPR analysis identified PPARγ as the potential target of 2 and 4. In vivo zebrafish studies further demonstrated that 2 and 4 exhibited remarkable anti-Alzheimer's disease (AD) effects with no detectable toxicity or teratogenicity. Thus, 2 and 4 could activate PPARγ and show promise as anti-AD agents.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Alzheimer DiseasePhloroglucinolHypericumZebrafishAnimalsMolecular StructurePPAR gammaHumansPrenylationMice

Substanzen

PhloroglucinolPPAR gamma

Autor:innen und Institutionen

  • Fujian Provincial Key Laboratory of Innovative Drug Target, School of Pharmaceutical Sciences, Xiamen University, Xiamen 361005, China.
  • Engineering Research Center of Zebrafish Models for Human Diseases and Drug Screening of Shandong Province, Biology Institute, Qilu University of Technology (Shandong Academy of Sciences), Jinan 250103, China.

ORCID-Profile: Haifeng Chen

Förderung

  • Natural Science Foundation of Fujian Province
  • National Natural Science Foundation of China

Zitieren

APA

Tian, W., He, S., Zhong, S., Wang, M., Lin, Y., Sun, J., Wang, G., Li, X., & Chen, H. (2025). Seco-Prenylated Butylphloroglucinol Derivatives from Hypericum elodeoides and Their Anti-Alzheimer’s Disease Activities. Organic Letters. https://doi.org/10.1021/acs.orglett.5c02367

Vancouver

Tian W, He S, Zhong S, Wang M, Lin Y, Sun J, et al. Seco-Prenylated Butylphloroglucinol Derivatives from Hypericum elodeoides and Their Anti-Alzheimer’s Disease Activities. Organic Letters. 2025. doi:10.1021/acs.orglett.5c02367

BibTeX
@article{Tian2025,
  author = {Tian, Wenjing and He, Shoulun and Zhong, Shengfei and Wang, Miaoyunhuan and Lin, Yingting and Sun, Jingyu and Wang, Guanghui and Li, Xiaobin and Chen, Haifeng},
  title = {Seco-Prenylated Butylphloroglucinol Derivatives from Hypericum elodeoides and Their Anti-Alzheimer’s Disease Activities},
  journal = {Organic Letters},
  year = {2025},
  doi = {10.1021/acs.orglett.5c02367}
}
Kostenlos starten →